LSE : 0HNC.L

BioMarin Pharmaceutical Inc. — News

$59.31 USD

$1.27 (2.19%)

Volume
181
Average Volume
5.97K
Market Capitalization
$10.56B
P/E Ratio
42.38
Dividend Yield
0.00%
Price Target
Year High
$99.65
Year Low
$58.89
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$5.81
Source Headline

Get 0HNC.L Insider Trade Alerts

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

0HNC.L Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

0HNC.L Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-16 Citigroup Maintain Buy Buy
2026-07-07 RBC Capital Maintain Sector Perform Sector Perform
2026-05-22 Canaccord Genuity Maintain Buy Buy
2026-05-19 B of A Securities Maintain Buy Buy
2026-05-18 HC Wainwright & Co. Maintain Neutral Neutral
2026-05-07 Canaccord Genuity Maintain Buy Buy
2026-05-05 Evercore ISI Group Maintain Outperform Outperform
2026-05-05 Morgan Stanley Maintain Overweight Overweight
2026-05-05 Bernstein Maintain Outperform Outperform
2026-05-05 HC Wainwright & Co. Maintain Neutral Neutral
2026-05-05 RBC Capital Maintain Sector Perform Sector Perform
2026-03-11 B of A Securities Maintain Buy Buy
2026-03-04 Barclays Maintain Overweight Overweight
2026-03-02 HC Wainwright & Co. Maintain Neutral Neutral
2026-03-02 Freedom Broker Maintain Buy Buy
2026-02-26 Canaccord Genuity Maintain Buy Buy
2026-02-25 HC Wainwright & Co. Maintain Neutral Neutral
2026-02-25 Bernstein Maintain Outperform Outperform
2026-02-25 Guggenheim Maintain Buy Buy
2026-02-24 Oppenheimer Maintain Outperform Outperform
2026-02-18 Wells Fargo Maintain Overweight Overweight
2026-02-06 Piper Sandler Maintain Overweight Overweight
2026-01-20 Canaccord Genuity Upgrade Hold Buy